Q3 2024 NeueHealth Inc Earnings Call Transcript
Key Points
- NeueHealth Inc (NEUE) delivered its strongest financial performance to date in the third quarter of 2024, with an adjusted EBITDA of $9.4 million.
- The company served approximately 509,000 consumers across its NeueCare and NeueSolutions segments, exceeding its full-year guidance range.
- NeueHealth Inc (NEUE) is focused on diversifying and growing its consumer base across various product categories, including the ACA marketplace, Medicare, and Medicaid.
- The company expanded its footprint in Central Florida, leveraging strong relationships with payer partners to grow the number of consumers served.
- NeueHealth Inc (NEUE) acquired full ownership of Centrum Health, simplifying its corporate structure and streamlining operations to support its value-driven care model.
- NeueHealth Inc (NEUE) reported an operating loss of $5.8 million in its NeueSolutions segment for the third quarter.
- The wind down of the ACA insurance business is ongoing, with remaining liabilities and obligations still being addressed.
- The company's NeueSolutions segment faced moderately lower medical costs, impacting overall financial performance.
- Despite strong performance, the company is still in the process of retrieving capital from discontinued entities.
- NeueHealth Inc (NEUE) faces risks and uncertainties that could cause actual results to differ materially from expectations, as highlighted in their forward-looking statements.
Ladies and gentlemen, welcome to the NeueHealth for quarter 2024. A next call. My name is Kenneth and I'll be coordinating your call today. I will now hand you over to your host, Emily Lombardi to begin. Please go ahead.
Good morning and welcome to NeueHealth third quarter 2024 earnings conference call. As a reminder, this call is being recorded leading the call today are NeueHealth President and CEO Mike Mikan; and CFO, Jay Matushak.
Before we begin, we want to remind you that this call may contain forward-looking statements under US federal securities laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations.
A description of some of the risks and uncertainties can be found in the reports that we file with the securities and exchange commission, including the risk factors in our current and periodic reports. We file with the SEC except as required by law, we undertake no
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

